Skip to main content

Table 2 SF-36 Health Survey Scores Before and After the Cardio-Oncology Risk Reduction Program

From: Patient reported physical and mental health changes associated with a comprehensive cardiovascular risk reduction program for women with breast cancer receiving potentially cardiotoxic chemotherapy

SF-36 Sub-Scale Measures

Baseline

Follow-up

Difference

Effect Size

P-value

Physical Functioning

47.7 ± 9.8

44.3 ± 12.3

−3.4 ± 9.0

−0.38

0.07

Physical Role

42.6 ± 12.5

39.9 ± 13.9

−2.7 ± 14.3

−0.19

0.30

Bodily Pain

45.2 ± 9.5

44.3 ± 11.6

−0.8 ± 12.1

−0.07

0.48

General Health Perception

44.9 ± 10.1

42.6 ± 10.5

−2.3 ± 11.1

−0.21

0.26

Mental Health

44.3 ± 13.3

49.4 ± 11.6

5.1 ± 10.8

0.47

0.004

Emotional Role Limitations

45.6 ± 13.4

47.8 ± 12.6

2.2 ± 11.5

0.19

0.21

Social Functioning

44.9 ± 13.1

42.6 ± 12.6

−2.3 ± 13.4

−0.17

0.36

Vitality/Energy

47.3 ± 11.8

44.8 ± 13.4

−2.5 ± 11.2

−0.22

0.23

Physical Component Summary (PCS)

46.2 ± 9.9

40.9 ± 11.9

−5.4 ± 10.2

−0.53

0.005

Mental Component Summary (MCS)

45.0 ± 14.0

48.8 ± 11.5

3.8 ± 10.4

0.37

0.02

  1. Values listed as means ± standard deviation; Bold indicates statistical significance result